We are live on
!
Find out more
MNA
Manning & Napier Advisors Portfolio holdings
AUM
$7.8B
1-Year Est. Return
25.03%
This Fund
S&P 500
This Quarter
Est. Return
+15.96%
1 Year Est. Return
+25.03%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.8B
AUM Growth
+$707M
(+10%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-1.74%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
885
New
270
Increased
236
Reduced
238
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tenet Healthcare
THC
|
+$166M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$157M |
| 3 |
Knight Transportation
KNX
|
+$154M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$133M |
| 5 |
Ametek
AME
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$96.8M |
| 2 |
TransUnion
TRU
|
+$88M |
| 3 |
Cadence Design Systems
CDNS
|
+$71.2M |
| 4 |
Sabesp
SBS
|
+$70.6M |
| 5 |
NVIDIA
NVDA
|
+$65.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Miscellaneous | 18.14% |
| 3 | Financials | 13.71% |
| 4 | Healthcare | 12.57% |
| 5 | Consumer Discretionary | 9.57% |
Similar funds
FFM
PC
EMPI
BFG
AAB
NAMA
PFA
AL
Manning & Napier Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Manning & Napier Advisors held 885 positions worth $7.8B, up 10% from $7.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Manning & Napier Advisors's Q2 2026 filing shows 270 new, 236 increased, 238 reduced and 21 closed positions. Its largest new stake was Tenet Healthcare: 901,645 shares worth $169M. The largest sale was Vertex Pharmaceuticals, an estimated $96.8M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Financials.
- Manning & Napier Advisors's largest Q2 2026 buy was Tenet Healthcare: 901,645 shares worth $169M.
- Manning & Napier Advisors added most to Vanguard Intermediate-Term Treasury ETF in Q2 2026, an estimated $157M increase.
- Manning & Napier Advisors's biggest Q2 2026 reduction was Vertex Pharmaceuticals, cutting an estimated $96.8M.
- Manning & Napier Advisors fully exited Plains All American Pipeline in Q2 2026, selling an estimated $4.47M.
- Manning & Napier Advisors's ten largest holdings make up 32% of its $7.8B portfolio in Q2 2026.
- Manning & Napier Advisors opened 270 new positions and closed 21 in Q2 2026.
- Manning & Napier Advisors's portfolio value rose 10% quarter-over-quarter to $7.8B.
Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.